Medicare covers Ozempic when prescribed for Type 2 diabetes, but does NOT cover it when prescribed solely for weight loss. The same applies to similar GLP-1 drugs like Mounjaro and Trulicity.
Medicare Part D plans cover Ozempic for diabetes, but how much you pay depends heavily on the specific plan's formulary tier and your situation under the new 2026 Part D rules.
Coverage status by indication:
- Type 2 diabetes — covered by most Part D plans (in formulary). Tier 2 or Tier 3 commonly.
- Cardiovascular risk reduction in T2D patients — covered (FDA-approved indication, eligible for Part D).
- Weight loss alone (Wegovy, Zepbound for non-diabetic obesity) — NOT covered by Medicare. Federal law explicitly excludes weight-loss drugs from Part D.
- Cardiovascular risk reduction in non-diabetic patients with obesity — Medicare expanded coverage for Wegovy in 2024 for this specific indication. Eligible Medicare members may now get Wegovy for cardiovascular risk reduction. Confirm your plan's specific policy.
Cost in 2026 with the $2,000 cap: Once you spend $2,000 out-of-pocket on covered Part D drugs in a calendar year, you pay $0 for additional covered drugs for the rest of that year. For someone whose only expensive drug is Ozempic at ~$200/month copay, you'd hit the $2,000 cap in October and pay nothing November–December.
The Medicare Prescription Payment Plan (M3P) lets you spread that $2,000 across 12 monthly payments of $166.67 instead of paying it all early in the year. Total cost is the same, but cash flow is smoother — useful if you start an expensive drug in January.
Watch for:
- Prior authorization — most plans require your doctor to document T2D diagnosis and that other drugs failed before approving Ozempic
- Step therapy — some plans require you to try metformin and other older drugs first
- Pharmacy network — using an out-of-network pharmacy can void coverage
What to do next: [Look up Ozempic coverage on every Part D plan in your ZIP](/tools/drug-pricing/), or call (866) 534-1886 — we'll check your specific situation against every plan's formulary, prior auth rules, and cost. Free.